BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38145031)

  • 1. Characteristics of the Patients Aged Less than 40 Years Operated for a Renal Mass.
    Ilktac A; Dogan B; Ersoz C; Coban G; Kalkan S
    J Kidney Cancer VHL; 2023; 10(4):20-27. PubMed ID: 38145031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral non-familial renal cell carcinoma.
    Grimaldi G; Reuter V; Russo P
    Ann Surg Oncol; 1998 Sep; 5(6):548-52. PubMed ID: 9754765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Features and Survival Data of Localized Renal Masses in Young Adults.
    Aslan R; Taken K; Eryılmaz R
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3233-3236. PubMed ID: 30486625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive clinicopathological features of Von Hippel-Lindau-associated hereditary renal cell carcinoma: A single-institution study.
    Hong B; Zhang Z; Zhou J; Ma K; Zhang J; Cai L; Zhang N; Gong K
    Oncol Lett; 2019 May; 17(5):4600-4606. PubMed ID: 30944649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tumors in young adults.
    Eggener SE; Rubenstein JN; Smith ND; Nadler RB; Kontak J; Flanigan RC; Waters WB; Picken M; Campbell SC
    J Urol; 2004 Jan; 171(1):106-10. PubMed ID: 14665855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up.
    Somani BK; Nabi G; Thorpe P; N'Dow J; Swami S; McClinton S;
    Eur Urol; 2007 May; 51(5):1289-95; discussion 1296-7. PubMed ID: 17081679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.
    Fujii Y; Komai Y; Saito K; Iimura Y; Yonese J; Kawakami S; Ishikawa Y; Kumagai J; Kihara K; Fukui I
    Urology; 2008 Sep; 72(3):598-602. PubMed ID: 18649929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma.
    Yao M; Yoshida M; Kishida T; Nakaigawa N; Baba M; Kobayashi K; Miura T; Moriyama M; Nagashima Y; Nakatani Y; Kubota Y; Kondo K
    J Natl Cancer Inst; 2002 Oct; 94(20):1569-75. PubMed ID: 12381710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
    Zhang YS; Yu HY; Dong F; Li HZ
    Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
    Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
    Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
    Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
    Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.
    Cooper CJ; Teleb M; Dwivedi A; Rangel G; Sanchez LA; Laks S; Akle N; Nahleh Z
    Rare Tumors; 2015 Feb; 7(1):5583. PubMed ID: 25918603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
    Jeon HG; Lee SR; Kim KH; Oh YT; Cho NH; Rha KH; Yang SC; Han WK
    Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.